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Prevalence, risk factor analysis, and follow-up of infections
caused by three feline hemoplasma species in cats in Switzerland
Abstract
Recently, a third novel feline hemotropic Mycoplasma sp. (aka hemoplasma), "Candidatus Mycoplasma
turicensis," in a cat with hemolytic anemia has been described. This is the first study to investigate the
prevalence, clinical manifestations, and risk factors for all three feline hemoplasma infections in a
sample of 713 healthy and ill Swiss cats using newly designed quantitative real-time PCR assays.
"Candidatus Mycoplasma haemominutum" infection was detected in 7.0% and 8.7% and Mycoplasma
haemofelis was detected in 2.3% and 0.2% of healthy and ill cats, respectively. "Candidatus
Mycoplasma turicensis" was only detected in six ill cats (1.1%); three of them were coinfected with
"Candidatus Mycoplasma haemominutum." The 16S rRNA gene sequence of 12 Swiss hemoplasma
isolates revealed >98% similarity with previously published sequences. Hemoplasma infection was
associated with male gender, outdoor access, and old age but not with retrovirus infection and was more
frequent in certain areas of Switzerland. "Candidatus Mycoplasma haemominutum"-infected ill cats
were more frequently diagnosed with renal insufficiency and exhibited higher renal blood parameters
than uninfected ill cats. No correlation between hemoplasma load and packed cell volume was found,
although several hemoplasma-infected cats, some coinfected with feline immunodeficiency virus or
feline leukemia virus, showed hemolytic anemia. High M. haemofelis loads (>9 x 10(5) copies/ml
blood) seem to lead to anemia in acutely infected cats but not in recovered long-term carriers. A
repeated evaluation of 17 cats documented that the infection was acquired in one case by blood
transfusion and that there were important differences among species regarding whether or not antibiotic
administration led to the resolution of bacteremia.
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Recently, a third novel feline hemotropic Mycoplasma sp. (aka hemoplasma), “Candidatus Mycoplasma
turicensis,” in a cat with hemolytic anemia has been described. This is the first study to investigate the
prevalence, clinical manifestations, and risk factors for all three feline hemoplasma infections in a sample of
713 healthy and ill Swiss cats using newly designed quantitative real-time PCR assays. “Candidatus Myco-
plasma haemominutum” infection was detected in 7.0% and 8.7% and Mycoplasma haemofelis was detected in
2.3% and 0.2% of healthy and ill cats, respectively. “Candidatus Mycoplasma turicensis” was only detected in
six ill cats (1.1%); three of them were coinfected with “Candidatus Mycoplasma haemominutum.” The 16S
rRNA gene sequence of 12 Swiss hemoplasma isolates revealed >98% similarity with previously published
sequences. Hemoplasma infection was associated with male gender, outdoor access, and old age but not with
retrovirus infection and was more frequent in certain areas of Switzerland. “Candidatus Mycoplasma haemo-
minutum”-infected ill cats were more frequently diagnosed with renal insufficiency and exhibited higher renal
blood parameters than uninfected ill cats. No correlation between hemoplasma load and packed cell volume
was found, although several hemoplasma-infected cats, some coinfected with feline immunodeficiency virus or
feline leukemia virus, showed hemolytic anemia. High M. haemofelis loads (>9  105 copies/ml blood) seem to
lead to anemia in acutely infected cats but not in recovered long-term carriers. A repeated evaluation of 17 cats
documented that the infection was acquired in one case by blood transfusion and that there were important
differences among species regarding whether or not antibiotic administration led to the resolution of
bacteremia.
Hemobartonella felis, the causative agent of feline infectious
anemia, has recently been reclassified as a hemotropic myco-
plasma (hemoplasma), and two different species, named My-
coplasma haemofelis and “Candidatus Mycoplasma haemo-
minutum,” have been recognized worldwide (6, 8, 11, 12, 16,
20, 22, 23, 27, 29, 31). In experimental infection studies, M.
haemofelis seemed more pathogenic than “Candidatus Myco-
plasma haemominutum” (11, 32), and an influence of retrovi-
ral status on the clinical manifestation of the latter is suspected
(4, 13, 14). Recently, we identified a third novel and unique
feline hemoplasma isolate, herein designated “Candidatus My-
coplasma turicensis,” in a Swiss cat with a history of severe
intravascular hemolysis (33). After experimental transmission
to two specific-pathogen-free (SPF) cats, “Candidatus Myco-
plasma turicensis” induced mild to severe anemia. Phyloge-
netic analyses based on the 16S rRNA gene sequence data
revealed that “Candidatus Mycoplasma turicensis” was closely
related to Mycoplasma coccoides and Mycoplasma haemomuris,
both rodent hemoplasma species (7, 15, 30).
This is the first study to investigate the prevalence, clinical
manifestations, and risk factors for infection for all three feline
hemoplasma species. Diagnosis, quantification, and follow-up
of hemoplasma infection were performed using three newly
designed sensitive real-time PCR assays.
MATERIALS AND METHODS
Sample collection. A total of 996 feline EDTA-anticoagulated blood samples
were available. They comprised initial samples from 713 Swiss cats and 283
follow-up samples that were sought specifically to monitor the course of hemo-
plasma infections. The initial samples were derived from 86 healthy and 627 ill
cats. Ninety-eight cats were sampled because a hemoplasma infection was sus-
pected (designated “preselected samples”).
Hematology, biochemistry, and urine analysis. For the ill cats, all the param-
eters requested by the attending veterinarian were analyzed. For most of the
healthy cats, only packed cell volume (PCV) values were determined. Hemo-
grams were performed using a Cell-Dyn 3500 system (Abbott, Baar, Switzer-
land). Blood smears were Giemsa stained using an AMES Hema Tek slide
stainer (Bayer, Zu¨rich, Switzerland) and visually evaluated for white blood cell
differential counts, red blood cell morphological characteristics, and the presence
of hemoplasmas. Aggregate reticulocytes were visually counted after brilliant
cresyl blue staining. Cats with a PCV of 33% (5% quantile [see below]) were
considered anemic. Regeneration was defined by a reticulocyte count of60,000
reticulocytes/l. Serum biochemistry was performed using a Cobas Integra 700
system (Roche Diagnostics, Rotkreuz, Switzerland) and included bilirubin, glu-
cose, blood urea nitrogen (BUN), creatinine, protein, albumin, cholesterol, al-
kaline phosphatase, aspartate aminotransferase, alanine aminotransferase,
lipase, sodium, chloride, potassium, and phosphorus. Urine analysis comprised
gross appearance, specific gravity, urine pH (Neutralit; Merck AG, Dietikon,
Switzerland), urine nitrite, protein, glucose, ketones, urobilinogen, bilirubin,
blood (Combur-Test; Roche), and the urine protein-to-creatinine ratio (Cobas
Integra 700). Reference ranges are stated as 5% and 95% quantiles.
DNA extraction. DNA was purified from 200 l blood using the MagNaPure
LC DNA Isolation Kit I (Roche). To monitor for cross-contamination, negative
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controls consisting of 200 l phosphate-buffered saline were concurrently pre-
pared with each batch of 11 to 15 samples.
Development of quantitative real-time PCR assays and standards. Species-
specific oligonucleotides were designed as follows: for “Candidatus Mycoplasma
haemominutum,” forward primer 5-GAA AGT CTG ATG GAG CAA TAC
CAT-3, reverse primer 5-CTG GCA CAT AGT TWG CTG TCA CTT A-3,
and probe 6-carboxyfluorescein–AAG GCT TAA TCA TTT CCT-minor groove
binder were used; for M. haemofelis, forward primer 5-GAA AGT CTG ATG
GAG CAA TAC CAT-3, reverse primer 5-CTG GCA CAT AGT TWG CTG
TCA CTT A-3, and probe VIC-AGT ACT ATC ATA ATT ATC CCT CG-
minor groove binder were used. For “Candidatus Mycoplasma turicensis,” a
previously published real-time PCR assay was used (33). The PCR mixtures were
comprised of 12.5 l 2 qPCR Mastermix (Eurogentec, Seraing, Belgium), 880
nM of each primer, 200 nM probe, and 5 l template DNA made up to 25 l with
water. The amplification buffer contained dUTP for use with uracil-N-glyco-
sylase to prevent carryover of PCR amplicons. Assays were performed using an
ABI PRISM 7700 sequence detection system (Applied Biosystems, Rotkreuz,
Switzerland). The first 500 samples were subjected to conventional (16) and
real-time PCR. The conventional PCR, although able to amplify all three feline
hemoplasma isolates, cannot differentiate between M. haemofelis and “Candidatus
Mycoplasma turicensis.” DNA samples from uninfected SPF cats and water were
used as negative controls. DNA from the following bacteria was used to deter-
mine the specificity of the real-time PCR assays: Chlamydophila felis, Pasteurella
multocida, Bartonella henselae, Mycoplasma penetrans, Mycoplasma equigenitalium,
Mycoplasma argini, Mycoplasma agalactiae, Mycoplasma suis, Mycoplasma wenyo-
nii, Mycoplasma haemocanis, and “Candidatus Mycoplasma haematoparvum.”
For absolute quantification, plasmids containing the cloned 16S rRNA gene of
“Candidatus Mycoplasma haemominutum,” M. haemofelis, or “Candidatus My-
coplasma turicensis” were generated as described below. Purified DNA was
linearized, quantified, and serially 10-fold diluted in a solution of 30 g/ml of
salmon sperm DNA (Invitrogen, Basel, Switzerland).
Sequencing of 16S rRNA genes. The near-complete 16S rRNA genes from 12
Swiss hemoplasma isolates (five “Candidatus Mycoplasma haemominutum,” four
M. haemofelis, and three “Candidatus Mycoplasma turicensis” isolates) were
sequenced. For “Candidatus Mycoplasma turicensis,” the sequencing method has
been described previously (33). For “Candidatus Mycoplasma haemominutum”
and M. haemofelis, species-specific primers (for “Candidatus Mycoplasma hae-
mominutum,” forward primer 5-AAG TCG AAC GAA GAG GGT TTA CT
C-3 and reverse primer 5-TTW AAT ACG GTT TCA ACT AGT ACT TTC
TCC-3 were used; for M. haemofelis, forward primer 5-TCG AAC GGA YYT
TGG TTT CG-3 and reverse primer 5-CAA ATG AAT GTA TTT TTA AAT
GCC CAC-3 were used) that amplify 1,354 bp and 1,309 bp of the gene,
respectively, were designed. The reaction mixture contained 5 l of 5 HF PCR
buffer (Finnzymes; BioConcept, Allschwil, Switzerland), 500 nM each primer,
200 M each deoxynucleoside triphosphate (Sigma-Aldrich, Buchs, Switzer-
land), 1 U Phusion High-Fidelity DNA polymerase (Finnzymes), and 5 l tem-
plate DNA made up to 25 l with water. The program was as follows: 98°C for
3 min; 35 cycles of 98°C for 10 s, 63 to 68°C for 30 s, and 72°C for 1 min; and a
final elongation step at 72°C for 10 min. PCR products were gel purified with a
MinElute gel extraction kit (QIAGEN, Hombrechtikon, Switzerland) and cloned
using the Zero Blunt TOPO PCR cloning kit (Invitrogen), and plasmid DNA was
purified using a QIAprep Spin Miniprep kit (QIAGEN). Sequencing was per-
formed with M13 forward and reverse primers and an internal primer (5-AGC
AAT ACC ATG TGA ACG ATG AA-3) using the BigDye Terminator cycle
sequencing kit (Applied Biosystems) and standard cycling conditions. Products
were purified with DyeEx Spin columns (QIAGEN) and analyzed with an ABI
PRISM 310 genetic analyzer (Applied Biosystems). For sequence comparison,
the GCG Wisconsin Package (Accelrys GmbH, Munich, Germany) was used.
Serological assays and FeLV PCR. To diagnose feline leukemia virus (FeLV)
infection, p27 antigenemia was detected by enzyme-linked immunosorbent assay
(19); positive results were confirmed by real-time PCR (24). Feline immunode-
ficiency virus (FIV) antibodies were measured by enzyme-linked immunosorbent
assay (5); positive results were confirmed by Western blot analysis (18).
Statistical evaluation. For observed prevalences, 95% confidence intervals
(CIs) were calculated. Up to 104 different parameters per cat were compiled and
analyzed with Excel (Microsoft, Wallisellen, Switzerland), Analyze-it Clinical Lab-
oratory (Analyze-it Software, Leeds, United Kingdom), and Prism (GraphPad, San
Diego, CA) software. The data included date of blood collection; anamnesis (n
19 [breed, age, gender, place of domicile, outdoor access, number of cats in the
household, foreign travel, vaccination status, deworming, reason for clinical
presentation, appetite, drinking, weight loss, constitution, defecation, urination,
lameness, previous disease, and previous treatment]); clinical examination find-
ings (n  27); hematological (n  16), biochemical (n  16), and urine (n  11)
parameters; serology (n 3 [FIV, FeLV, and feline coronavirus]); PCR analyses
(n  7); and diagnosis (n  5). Correlation between PCV and hemoplasma load
in blood (copy numbers of DNA template per milliliter of blood) was assessed by
the Spearman rank correlation coefficient (rs). Blood loads were tested for
statistical differences among cats infected with different hemoplasmas by the
Kruskal-Wallis one-way analysis of variance by ranks and the Dunn’s posttest for
multiple comparisons. For spatial association, the results were analyzed based on
the zip codes of the place of domicile of the sampled cats; the frequency of each
hemoplasma infection was compared between cats living in the West (zip codes
1000 to 3000), in the South (zip codes 6500 to 7000), and in the North-East
(the rest of the zip codes) of Switzerland. Risk factors for hemoplasma infections
were analyzed with the Mann-Whitney U test for continuous variables (age,
PCV, BUN, creatinine, protein, and lipase) and with Fisher’s exact test (cell
frequencies of 5) or chi-square test (cell frequencies of 5) for categorical
variables (gender, breed, hemoplasma coinfection, FIV and FeLV infection,
outdoor access, place of domicile, and renal insufficiency). Differences were
considered significant if the P value was 0.05.
Nucleotide sequence accession numbers. The 16S rRNA gene nucleotide se-
quences generated from “Candidatus Mycoplasma haemominutum,” “Candida-
tus Mycoplasma turicensis,” and M. haemofelis isolates have been submitted to
GenBank under accession numbers DQ157141 to DQ157149, DQ157150 to
DQ157154, and DQ157155 to DQ157160, respectively.
RESULTS
Hemoplasma-specific real-time PCR assays. Amplification
of the newly developed real-time PCR assays specific for “Can-
didatus Mycoplasma haemominutum,” M. haemofelis, and
“Candidatus Mycoplasma turicensis” using 10-fold serial dilu-
tions of plasmid standards was linear over 9 orders of magni-
tude. All cats found to be hemoplasma positive by conven-
tional PCR yielded positive results in the corresponding
specific real-time PCR. The real-time PCR assays showed no
cross-reactivity with other feline hemoplasmas in that each
yielded negative results when 104 copies/reaction of standard
plasmid DNA of nonmatching hemoplasma species were used
as a template. As expected from the sequence comparison, M.
haemocanis-derived DNA tested positive in the real-time PCR
assay for M. haemofelis, and “Candidatus Mycoplasma haema-
toparvum”-derived DNA was amplified by the real-time PCR
assay for “Candidatus Mycoplasma haemominutum.” All other
template DNA derived from various bacterial pathogens did
not result in product amplification. All negative controls were
negative. The PCR assays were able to specifically detect 1
copy/reaction of “Candidatus Mycoplasma haemominutum”
TABLE 1. Gender, breed, FIV and FeLV infection status, and
outdoor access of healthy and ill cats
Variable No. of healthycats (%)
No. of ill
cats (%)
Odds
ratio 95% CI P
Gender
Female 32 (37.2) 263 (44.4) 1.0
Male 54 (62.8) 330 (55.6) 0.74 0.47–1.2 0.26
Breed
Nonpedigree 74 (86.0) 529 (84.4) 1.0
Pedigree 12 (14.0) 98 (15.6) 1.1 0.60–2.2 0.81
FIV
Negative 82 (95.3) 408 (96.0) 1.0
Positive 4 (4.7) 17 (4.0) 0.85 0.28–2.6 0.97
FeLV
Negative 83 (96.5) 437 (96.9) 1.0
Positive 3 (3.5) 14 (3.1) 0.89 0.25–3.2 1.0
Outdoor access
No 11 (14.5) 187 (38.1) 1.0
Yes 65 (85.5) 304 (61.9) 0.28 0.14–0.54 0.0001
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(10/10 reactions positive), M. haemofelis (9/10 reactions posi-
tive), and “Candidatus Mycoplasma turicensis” (10/10 reac-
tions positive), respectively.
Characteristics of cases. Case characteristics are shown in
Tables 1 and 2. Healthy cats were significantly younger, had a
higher PCV, and more frequently had outdoor access than ill cats.
Gender, breed, and frequency of FIV and FeLV infections were
not significantly different between healthy and ill cats.
Prevalence. Of the 615 nonpreselected samples, 52 (8.5%;
95% CI, 6.3% to 10.7%) tested PCR positive for “Candidatus
Mycoplasma haemominutum,” 3 (0.5%; 95% CI, 0% to 1.1%)
tested positive for M. haemofelis, and 6 (1%; 95% CI, 0.2% to
1.8%) tested positive for “Candidatus Mycoplasma turicensis.”
Three of the six “Candidatus Mycoplasma turicensis”-infected
cats were coinfected with “Candidatus Mycoplasma haemo-
minutum” (50%; P  0.022). When the preselected samples
were included (total, n  713), 71 (10.0%; 95% CI, 7.8% to
12.2%) tested PCR positive for “Candidatus Mycoplasma hae-
mominutum,” 11 (1.5%; 95% CI, 0.6% to 2.4%) tested positive
for M. haemofelis, and 9 (1.3%; 95% CI, 0.5% to 2.1%) tested
positive for “Candidatus Mycoplasma turicensis.” Six of the
nine “Candidatus Mycoplasma turicensis”-infected cats were
coinfected with “Candidatus Mycoplasma haemominutum”
(67%; P  0.0001), whereas 2 of the 71 “Candidatus Myco-
plasma haemominutum”-infected animals tested positive for
M. haemofelis.
Antibiotic treatment with enrofloxacin or doxycycline has
been shown to be effective against hemoplasma infection (10,
28) and could therefore influence the detectability of these
agents by PCR. Concurrent antibiotic treatment was reported
for 73 cats: 16 cats were treated with enrofloxacin, 4 cats were
treated with doxycycline, and 53 cats were treated with other
antibiotics. One of 11 (9%) samples from doxycycline-treated
cats, 2 of 43 (4.7%) samples from enrofloxacin-treated cats,
and 7 of 105 (6.7%) samples derived from cats treated with
other antibiotics gave positive PCR results.
Sequencing of 16S rRNA gene. To confirm the PCR results
and to evaluate sequence variations among hemoplasma isolates,
the 16S rRNA genes from all three feline hemoplasma species
were sequenced. These data revealed more than 98% similarity
with previously published hemoplasma sequences (GenBank ac-
cession numbers AF271154, AY150977, and AY831867) (data
not shown).
Characteristics of hemoplasma PCR-positive cats. Among
nonpreselected cats, the prevalence of the three hemoplasma
species was not significantly different between healthy and ill
cats, and hemoplasma PCR-positive status was not associated
with anemia. Hemoplasma-infected cats were significantly
older than hemoplasma-uninfected cats (Table 3), and infec-
tion was associated with male gender, outdoor access (Table 4),
and living in the South and West of Switzerland (Table 5). No
significant difference was found for any hematology or biochem-
istry parameter between hemoplasma-infected and hemoplasma-
uninfected ill cats (data not shown).
Characteristics of “Candidatus Mycoplasma haemominu-
tum” PCR-positive cats. Including the preselected samples, 71
of 713 cats tested “Candidatus Mycoplasma haemominutum”
positive; infected cats were significantly older than uninfected
cats (Table 3), and PCR-positive status was associated with
male gender, outdoor access (Table 4), and living in the South
TABLE 3. Median age of hemoplasma- or “Candidatus Mycoplasma haemominutum”-negative and -positive cats
Organism and cat group
PCR negative PCR positive
PNo. of
cats
Median
age (yr)
95% CI
(yr)
No. of
cats
Median
age (yr)
95% CI
(yr)
Hemoplasma
Healthy cats 74 1.0 1.0–2.0 8 9.5 1.0–13 0.0029
Ill cats 497 7.0 6.0–8.0 63 10 10–12 0.0005
“Candidatus Mycoplasma
haemominutum”
Healthy cats 76 1.0 1.0–2.0 6 12 4.0–13 0.0006
Ill cats 504 7.0 6.0–8.0 56 11 10–12 0.0002
TABLE 2. Median age and PCV in healthy and ill cats
Variable and cat
group No. of cats Median 95% CI P
Age (yr)
Healthy cats 82 1.8 1.0–2.0 0.0001
Ill cats 560 8.0 7.0–9.0
PCV (%)
Healthy cats 86 36 35–38 0.0001
Ill cats 587 34 33–34
TABLE 4. Gender and outdoor access of hemoplasma-,
“Candidatus Mycoplasma haemominutum”-,
and M. haemofelis-positive cats
Organism and variable
No. of PCR
Odds
ratio 95% CI PNegative
(%)
Positive
(%)
Hemoplasma
Gender
Female 276 (45.8) 19 (24.7) 1.0
Male 326 (54.2) 58 (75.3) 2.6 1.5–4.4 0.0007
Outdoor access
No 188 (36.9) 11 (19.0) 1.0
Yes 322 (63.1) 47 (81.0) 2.5 1.3–4.9 0.010
“Candidatus Mycoplasma
haemominutum”
Gender
Female 277 (45.3) 18 (26.9) 1.0
Male 335 (54.7) 49 (73.1) 2.3 1.3–4.0 0.0059
Outdoor access
No 190 (36.8) 9 (17.6) 1.0
Yes 327 (63.2) 42 (82.4) 2.7 1.3–5.7 0.010
M. haemofelis
Gender
Female 295 (44.0) 0 (0) 1.0
Male 375 (56.0) 9 (100) 15 0–57 0.011
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and West of Switzerland (Table 5). In the ill cat population,
“Candidatus Mycoplasma haemominutum”-infected cats had
significantly higher BUN, creatinine, protein, and lipase levels
(Table 6) and were more frequently diagnosed with renal in-
sufficiency (P  0.021) than cats not infected with “Candidatus
Mycoplasma haemominutum.” In addition, infection with
“Candidatus Mycoplasma haemominutum” was significantly
associated with “Candidatus Mycoplasma turicensis” coinfec-
tion (P  0.0001) but not with retrovirus infections. Hemato-
logical parameters were not different between “Candidatus
Mycoplasma haemominutum”-infected and “Candidatus My-
coplasma haemominutum”-uninfected cats, and infection was
not associated with anemia. When 75 PCR-positive samples
(from 71 cats) were analyzed, no correlation between PCV and
“Candidatus Mycoplasma haemominutum” loads in the blood
could be found (Fig. 1A) (rs  0.11; CI, 0.12 to 0.33; P 
0.35). Two of the “Candidatus Mycoplasma haemominutum”-
infected cats exhibited PCVs of 15% with signs of acute
intravascular hemolysis; one cat was infected with FeLV and
was diagnosed with lymphatic leukemia, while the second cat
was coinfected with M. haemofelis.
Characteristics of M. haemofelis PCR-positive cats. Includ-
ing the preselected samples, 11 of 713 cats tested M. haemofelis
positive. Infection was significantly associated with male gen-
der (Table 4) and living in the South and West of Switzerland
(Table 5). All M. haemofelis-positive cats were nonpedigree
cats ranging in age from 1 to 10 years. The retroviral status of
five cats was known: one tested FeLV positive, and another cat
tested FIV positive. Nine out of 11 samples were from ill cats
including two cats with acute hemolysis at the time of sampling
and three cats that had shown signs of hemolysis within 2
months prior to sampling but that had recovered after doxy-
cycline-prednisolone treatment. No association between PCV
and M. haemofelis loads in the blood was found (Fig. 1B) (n 
10; rs  0.57; CI, 0.09 to 0.88; P  0.084). Three healthy cats
with PCV values within the reference range had M. haemofelis
loads of 1.6  106 to 2.8  108 copies/ml blood. Conversely,
two cats with moderate loads of 9.2  105 and 1.1  107
copies/ml blood had low PCV values of 12% (Fig. 1B). Both
animals were reported to have acute hemolysis at the time of
blood collection. One of these cats tested FIV positive and was
euthanized for humane reasons due to deteriorating health.
Characteristics of “Candidatus Mycoplasma turicensis” PCR-
positive cats. Including the preselected samples, 9 of 713 cats
tested “Candidatus Mycoplasma turicensis” positive. These nine
cats were all ill, nonpedigree cats from 3 to 16 years of age.
Seven cats were castrated males, and two cats were female
(one intact, one neutered). The retroviral status of four cats
was known, and one cat was FIV positive. Three of seven
“Candidatus Mycoplasma turicensis”-infected cats were ane-
mic. All five “Candidatus Mycoplasma turicensis”-infected cats
for which the modus vivendi was reported had outdoor access.
No correlation between “Candidatus Mycoplasma turicensis”
loads and PCV was found (Fig. 1C) (n  11; rs  0.38; CI,
0.80 to 0.28; P  0.25). One cat with a relatively high load
and low PCV was coinfected with FIV. “Candidatus Myco-
plasma turicensis”-infected cats exhibited significantly lower
hemoplasma loads in the blood (median copy number, 5.0 
102 copies/ml) than “Candidatus Mycoplasma haemominu-
tum”-infected cats (median copy number, 7.8  104 copies/ml;
P  0.0099; Dunn’s posttest, P  0.05) and M. haemofelis-
infected cats (median copy number, 5.1  105 copies/ml; P 
0.0099; Dunn’s posttest, P  0.01). The diagnoses of seven of
the nine “Candidatus Mycoplasma turicensis”-infected cats
were known: three cats had neoplasia (malignant lymphoma,
hepatocellular carcinoma, or fibrosarcoma), one cat had lower
urinary tract disease, one cat had a mandibular fracture, one
cat had lacerations, and one cat had immune-mediated hemo-
lytic anemia. Transmission of heparinized blood from the latter
cat to two SPF cats induced anemia in the recipients (33).
Course of “Candidatus Mycoplasma haemominutum” infec-
tion. Follow-up blood samples were available for 15 “Candi-
datus Mycoplasma haemominutum”-infected cats (Table 7 and
Fig. 2). Time periods of follow-up reached up to 8.5 months.
For 11 cats, all blood samples collected within a period of
several days to 7 months (two to six samples per cat) tested
PCR positive. Six of the 15 “Candidatus Mycoplasma haemo-
minutum”-infected cats were treated with antibiotics during
follow-up (cats 06, 51, 71, 74, 98, and 880) (Table 7). For four
of these cats (cats 71, 74, 98, and 880), each sample that was
collected tested PCR positive (up to 810 days of follow-up),
independent of antibiotic treatment. However, “Candidatus
TABLE 5. Place of domicile of hemoplasma-, “Candidatus
Mycoplasma haemominutum”-, and M. haemofelis-negative and
-positive cats
Organism and place of
domicile
No. (%) of cats with
PCR result was: Odds
ratio
95%
CI P
Negative Positive
Hemoplasma
South/West of Switzerland 23 (4.0) 8 (19.0) 5.6 2.3–13 0.0001
Rest of Switzerland 548 (96.0) 34 (81.0) 1.0
“Candidatus Mycoplasma
haemominutum”
South/West of Switzerland 26 (4.5) 5 (15.6) 4.0 1.4–11 0.017
Rest of Switzerland 555 (95.5) 27 (84.4) 1.0
M. haemofelis
South/West of Switzerland 27 (4.5) 4 (44.4) 17 4.3–67 0.0011
Rest of Switzerland 577 (95.5) 5 (55.6) 1.0
TABLE 6. Selected biochemical blood parameters of “Candidatus Mycoplasma haemominutum” PCR-negative and -positive ill cats
Variable
PCR negative PCR positive
Reference
range PNo. of
cats Median 95% CI
No. of
cats Median 95% CI
BUN (mg/dl) 438 23.6 11.5–86.2 40 29.2 12.6–78.3 20.8–35.4 0.014
Creatinine (mol/liter) 438 116 61.4–392 39 145 82.9–472 98.0–163 0.0003
Protein (g/liter) 436 68.0 49.0–82.3 37 72.0 57.4–87.8 64.0–80.0 0.0009
Lipase (U/liter) 407 17.0 8.0–55.8 35 20.0 12.4–117 8.0–26.0 0.019
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Mycoplasma haemominutum” loads decreased during treat-
ment, with a 6-fold reduction with doxycycline or spiramycin-
metronidazole treatment and a 10-fold reduction with enrofloxa-
cin-amoxicillin treatment. Two of these cats were retrovirus
positive: cat 71 was FeLV positive, and cat 98 was FIV positive.
In cat 71, an increase in hemoplasma load to 106 copies/ml
blood occurred several months after antibiotic treatment, yet
this was not associated with a drop in PCV (Fig. 2). Three of
the 15 “Candidatus M. haemominutum”-positive cats became
PCR negative during the follow-up period (cats 06, 51, and 78)
(Fig. 2); after enrofloxacin-amoxicillin treatment, cat 06 stayed
PCR negative for the remaining follow-up time (three samples,
1 month apart). This cat exhibited already low “Candidatus
Mycoplasma haemominutum” loads before treatment (100 to
4,700 copies/ml). Cat 78 yielded a negative PCR result on the
last blood sample taken, yet no antibiotic treatment was re-
ported. Cat 86 became infected with “Candidatus Mycoplasma
haemominutum” via a blood transfusion. This cat had nasal
mycosis with acute epistaxis and had received 56 ml of whole
blood from an unrelated blood donor cat. After transfusion,
cat 86 became PCR positive, with loads of 1.9  104 to 2.3 
104 copies/ml blood. No blood sample from the donor cat was
available for PCR analysis.
Course of M. haemofelis infection. Follow-up blood samples
for M. haemofelis infection were available for two cats (cats 15
and 880) (Table 7 and Fig. 2). Cat 15 was monitored for 124
days and was M. haemofelis PCR positive on all samples, with
loads ranging from 1.6  106 to 2.0  108 copies/ml blood. On
the second and third samples, the cat tested FeLV positive but
subsequently overcame FeLV antigenemia. Despite the pres-
ence of FeLV infection and high hemoplasma loads, this cat
remained healthy throughout and did not receive antibiotics at
any time.
Four blood samples collected during a follow-up period of
28 months were available from one cat (cat 880) coinfected
with M. haemofelis and “Candidatus Mycoplasma haemominu-
tum” (Table 7 and Fig. 2). The cat had a history of acute
hemolysis with pale mucous membranes, pyrexia, and severe
anemia (PCV, 13%) 44 days before the first blood sample was
analyzed. Following 4 weeks of treatment with tetracycline and
prednisolone, the cat recovered, and no relapse was reported.
The cat tested PCR positive for “Candidatus Mycoplasma hae-
mominutum” for each sample analyzed, with loads ranging
from 1.2 102 to 2.4 106 copies/ml blood. The M. haemofelis
loads varied dramatically, and only two of four samples tested
PCR positive. Within 12 days, a negative result and a positive
result with a very high load of 9.7  106 copies/ml blood were
found, yet antibiotic treatment was not given during this
period.
Course of “Candidatus Mycoplasma turicensis” infection.
Follow-up samples were available for two cats (cats 946 and
98) infected with “Candidatus Mycoplasma turicensis.” Cat
946, which was diagnosed with immune-mediated hemolytic
anemia (33), was monitored for 21 months (10 blood samples)
(Table 7 and Fig. 2). Before antibiotic treatment, the cat tested
“Candidatus Mycoplasma turicensis” positive for each of the
six blood samples analyzed over a period of 6 months, with
loads ranging from 9.6  102 to 7.4  104 copies/ml blood.
After doxycycline treatment (10 mg/kg/day orally for 14 days),
all four samples collected over a period of 1 year were PCR
negative for “Candidatus Mycoplasma turicensis.”
Cat 98, which was coinfected with “Candidatus Mycoplasma
haemominutum” and “Candidatus Mycoplasma turicensis,”
was monitored for 18 days (Table 7 and Fig. 2). The cat was
FIG. 1. Correlation between PCV (percent) (y axis) and hemoplasma
load (log DNA copy number per milliliter of blood) (x axis) in cats
infected with (A) “Candidatus Mycoplasma haemominutum,” (B) M. hae-
mofelis, and (C) “Candidatus Mycoplasma turicensis.” All PCR-positive
samples were included. Specific cats are indicated as follows: a, FeLV-
positive cats; b, FIV-positive cats; c, cats coinfected with “Candidatus
Mycoplasma haemominutum” and M. haemofelis; d, cats reported as
having acute hemolysis at the time of blood collection; e, cats reported as
having acute hemolysis within the last 2 months before blood collection.
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FIV positive and had gingival lymphoma. During the follow-up
period, the cat was irradiated four times and received spira-
mycin-metronidazole treatment for 9 days. Antibiotic treat-
ment was not associated with decreased “Candidatus Myco-
plasma turicensis” loads, and, indeed, loads increased 6.6-fold.
The cat was highly anemic during the entire observation pe-
riod, although hemolysis or regeneration was not evident.
DISCUSSION
This is the first study to show that all three feline hemo-
plasma species are prevalent in pet cats. The study was per-
formed with three newly designed real-time PCR assays that
proved to be highly sensitive and specific and thus accurate for
the diagnosis of feline hemoplasma infections.
In agreement with previously published studies (16, 25, 26),
“Candidatus Mycoplasma haemominutum” was also the most
prevalent hemoplasma in Swiss cats. The frequency of “Can-
didatus Mycoplasma turicensis” infection was found to be sim-
ilarly low compared to that of M. haemofelis infection. The
overall prevalence of hemoplasma infections in Swiss cats was
lower than that reported in the three aforementioned studies,
pointing to geographical variations in the distribution of feline
hemoplasmal species. Sequencing of a number of 16S rRNA
genes from isolates derived from Switzerland revealed almost-
complete identity to American, British, Australian, South Af-
rican, and Swiss isolates (16, 27, 29, 33).
There was no significant difference in hemoplasma preva-
lence between healthy and ill cats. This could imply that these
agents have a low pathogenic potential. Alternatively, the prev-
alence in the healthy cats investigated in this study could have
been overestimated, since they had significantly more outdoor
access than the ill cats. This could also explain why retroviral
infections were similarly prevalent in healthy and ill cats. In
addition, some of the ill cats had been treated with doxycycline
and enrofloxacin prior to blood sampling, which could have led
to the resolution of bacteremia and thus to an underestimation
of hemoplasma prevalence in ill cats.
Hemoplasma infection was not associated with anemia, and
hemoplasma blood loads were not correlated with PCV. This
appears especially remarkable for M. haemofelis; it is in contrast
to data from a previous study (26), and the pathogenic potential
of this agent has been demonstrated previously by different au-
thors (11, 32). We found acute hemolysis in 5 of 11 M. haemofelis-
infected cats, either at the time or within 2 months of blood
collection. However, high loads (106 copies/ml blood) were also
observed in healthy animals. One of these cats had recently un-
dergone hemolysis but had recovered completely. This led us to
hypothesize that cats acutely infected with M. haemofelis indeed
develop severe hemolysis in the presence of high hemoplasma
loads in blood but that chronically infected animals that recover
from acute illness can lack clinical signs, even in the presence of
remarkably high loads in the blood.
Two “Candidatus Mycoplasma haemominutum”-infected cats
had a PCV of 15% with signs of hemolysis. One of these cats
was FeLV positive with lymphatic leukemia, while the other cat
was coinfected with M. haemofelis. Our findings agree with pre-
vious observations that “Candidatus Mycoplasma haemominu-
tum” alone does not usually lead to significant anemia and that
cofactors are involved in the development of disease (11, 13). This
also seems to be the case for “Candidatus Mycoplasma turicensis”
infections. The highest “Candidatus Mycoplasma turicensis” load
was observed in an anemic FIV-coinfected cat, which had devel-
oped lymphopenia and gingival lymphoma. Interestingly, we
found that hemoplasma prevalence and loads in blood were
similar in retrovirus-infected and uninfected cats. We there-
fore assume that a retrovirus-positive status alone is insuffi-
cient to induce hemoplasma disease and that retrovirus-in-
duced immunosuppression or interaction with blood progenitor
cells is required for the manifestation of hemoplasma-induced
anemia.
Cats with outdoor access were more likely to be infected
TABLE 7. Course of infection in “Candidatus Mycoplasma haemominutum,” “Candidatus Mycoplasma turicensis,”
and M. haemofelis PCR-positive cats
Cat Observationperiod (days)
No. of PCR-positive
samples/total
samples analyzed
Hemoplasma species Copies/ml blood(range) Antibiotic treatment
03 6 2/2 “Candidatus Mycoplasma haemominutum” 1.1  105–1.2  105 Not reported
06 104 5/8 “Candidatus Mycoplasma haemominutum” 0–4.7  103 Enrofloxacin, amoxicillin
22 2 2/2 “Candidatus Mycoplasma haemominutum” 4.1  102–4.3  102 Not reported
41 1 2/2 “Candidatus Mycoplasma haemominutum” 2.5  104–1.1  105 Not reported
51 15 5/2 “Candidatus Mycoplasma haemominutum” 0–1.0  104 Amoxicillin
20 41 2/2 “Candidatus Mycoplasma haemominutum” 1.2  105–1.7  106 Not reported
61 100 2/2 “Candidatus Mycoplasma haemominutum” 1.0  105–1.2  105 Not reported
71 225 6/6 “Candidatus Mycoplasma haemominutum” 5.7  103–1.2  106 Enrofloxacin, amoxicillin
74 25 2/2 “Candidatus Mycoplasma haemominutum” 3.8  104–2.3  105 Doxycycline
78 255 2/3 “Candidatus Mycoplasma haemominutum” 0–1.5  105 Not reported
81 14 2/2 “Candidatus Mycoplasma haemominutum” 1.1  105–3.5  105 Not reported
86 14 2/5 “Candidatus Mycoplasma haemominutum” 0–2.3  104 Not reported
97 49 3/3 “Candidatus Mycoplasma haemominutum” 1.9  103–2.5  104 Not reported
880 854 4/4 “Candidatus Mycoplasma haemominutum” 1.2  102–2.4  106 Tetracycline
2/4 M. haemofelis 1  102–9.7  106
98 18 2/2 “Candidatus Mycoplasma haemominutum” 3.8  103–2.5  104 Spiramycin, metronidazole
2/2 “Candidatus Mycoplasma turicensis” 9.1  104–1.2  106
15 124 3/3 M. haemofelis 1.6  106–2.0  108 Not reported
946 646 6/10 “Candidatus Mycoplasma turicensis” 0–5.2  104 Doxycycline
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with hemoplasmas, supporting the hypothesis that these agents
are indirectly transmitted by blood-sucking arthropods like
ticks and fleas (17, 34). In line with this, we found geographical
variations in the distribution of hemoplasma infections within
Switzerland. The West and South, where infections were more
prevalent than in the remainder of the country, are known for
higher mean annual temperatures and for harboring additional
kinds of arthropods, i.e., Rhipicephalus sanguineus and Derma-
FIG. 2. Course of “Candidatus Mycoplasma haemominutum” (A to F and H), M. haemofelis (F to G), and “Candidatus Mycoplasma turicensis”
(H and I) infections. The loads are presented as log DNA copy number per milliliter of blood (left y axis); the PCV is given as a percentage (right
y axis). (A) Cat 71; (B) cat 06; (C) cat 78; (D) cat 86; (E) cat 51; (F) cat 880; (G) cat 15; (H) cat 98; (I) cat 946. Periods of antibiotic treatment
are indicated by gray areas; treatments are listed in Table 7. The time point of blood transfusion for cat 86 is indicated by an arrow (D). The lower
detection limit of the PCR assays (100 copies/ml blood) is indicated by a fine dotted line.
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centor reticulatus (1–3). However, in agreement with previous
studies (25, 26), the high prevalence of hemoplasma infections
in male cats speaks for a direct transmission. Recently, it was
demonstrated that a bold attitude makes outdoor male cats
more vulnerable to pathogens that are directly transmitted,
such as FIV (21). In addition, both “Candidatus Mycoplasma
haemominutum” and “Candidatus Mycoplasma turicensis”
have been detected by PCR in saliva of infected cats (9; B.
Willi, unpublished data). Whichever transmission prevails, the
finding that 50% of “Candidatus Mycoplasma turicensis”-
infected cats were coinfected with “Candidatus Mycoplasma
haemominutum” suggests that these two hemoplasma species
exhibit a similar way of transmission.
Overall, “Candidatus Mycoplasma turicensis” loads in blood
were found to be lower than those of M. haemofelis and “Can-
didatus Mycoplasma haemominutum.” While no explanation
can be given for this observation, it might explain why “Can-
didatus Mycoplasma turicensis” could not affirmatively be
identified visually by light microscopy on stained blood smears.
The present study observed for the first time an association
between “Candidatus Mycoplasma haemominutum” PCR-pos-
itive status and elevated BUN, creatinine, protein, and lipase
blood levels and the diagnosis of renal insufficiency. This as-
sociation could be causal but could also be accounted for by,
e.g., the older age of infected cats.
Interestingly, we observed different responses of the three
feline hemoplasma species to antibiotic treatment. A cat in-
fected with “Candidatus Mycoplasma turicensis” was able to
clear bacteremia after doxycycline treatment. The cat re-
mained PCR negative during the year-long follow-up period.
In line with this, two SPF cats experimentally infected with
“Candidatus Mycoplasma turicensis” eliminated the agent
spontaneously from peripheral blood (33). One of these cats
remained PCR negative in the 330-day follow-up period; im-
munosuppression with methylprednisolone did not reactivate
“Candidatus Mycoplasma turicensis” infection in this cat (B.
Willi, unpublished). Similarly, 3 of 15 “Candidatus Myco-
plasma haemominutum”-infected cats became PCR negative
either without antibiotic treatment or after antibiotic interven-
tion with enrofloxacin-doxycycline or amoxicillin. In contrast,
spontaneous or treatment-induced elimination of M. haemo-
felis was not observed, although in one cat, loads in the blood
fluctuated markedly, and the animal transiently tested PCR
negative for M. haemofelis.
It can be concluded from the present study that “Candidatus
Mycoplasma turicensis” is common in the Swiss pet cat popu-
lation. The pathogenic potential of this isolate seems to de-
pend mainly on cofactors such as iatrogenic or retrovirus-
induced immunosuppression or other as-yet-undefined factors.
Our observations suggest that doxycycline is effective against
this hemoplasma species. Treatment of infected cats should be
considered even in the absence of anemia, as apparent clear-
ance of the organism after antibiotic therapy was observed, and
immunosuppression or stress in an infected cat may lead to
severe acute hemolysis. Hemoplasma infection can be trans-
mitted via blood transfusion. As the recipient animals are often
in poor health, infection with M. haemofelis, but also with
“Candidatus Mycoplasma haemominutum” or “Candidatus My-
coplasma turicensis,” could represent a life-threatening event.
The screening of blood donor cats for infection with all three
feline hemoplasma species using sensitive and specific PCR
assays prior to transfusion is therefore highly recommended.
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